Chemokines and Chemokine Receptors: Standing at the Crossroads of Immunobiology and Neurobiology

Immunity

Volumn 31, Issue 5, 2009, Pages 711-721

  Ransohoff, Richard M ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA CHEMOKINE; BETA CHEMOKINE; CHEMOKINE; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CCR7; CHEMOKINE RECEPTOR CX3CR1; CHEMOKINE RECEPTOR CXCR2; CHEMOKINE RECEPTOR CXCR3; CHEMOKINE RECEPTOR CXCR5; CXCL11 CHEMOKINE; CXCL9 CHEMOKINE; EOTAXIN 3; FRACTALKINE; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; MONOCYTE CHEMOTACTIC PROTEIN 1;

ALLERGIC ENCEPHALOMYELITIS; AUTOIMMUNITY; BLOOD CELL; CELL INTERACTION; CELL MOTION; HUMAN; IMMUNE SYSTEM; IMMUNOBIOLOGY; MULTIPLE SCLEROSIS; NERVOUS SYSTEM; NERVOUS SYSTEM DEVELOPMENT; NERVOUS SYSTEM FUNCTION; NEUROBIOLOGY; NONHUMAN; PAIN; PARENCHYMA; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN LOCALIZATION; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; CHEMOKINES; HUMANS; IMMUNE SYSTEM; NEUROBIOLOGY; RECEPTORS, CHEMOKINE;

EID: 70449525704     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.immuni.2009.09.010     Document Type: Review

References (140)

1. Abbadie C. Chemokines, chemokine receptors and pain. Trends Immunol. 26 (2005) 529-534
2. Abbadie C., Lindia J.A., Cumiskey A.M., Peterson L.B., Mudgett J.S., Bayne E.K., DeMartino J.A., Macintyre D.E., and Forrest M.J. Impaired neuropathic pain responses in mice lacking the chemokine receptor CCR2. Proc. Natl. Acad. Sci. USA 100 (2003) 7947-7952
3. Acosta J.C., O'Loghlen A., Banito A., Guijarro M.V., Augert A., Raguz S., Fumagalli M., Da C.M., Brown C., Popov N., et al. Chemokine signaling via the CXCR2 receptor reinforces senescence. Cell 133 (2008) 1006-1018
4. Allen N.J., and Attwell D. A chemokine-glutamate connection. Nat. Neurosci. 4 (2001) 676-678
5. Alon R., and Feigelson S. From rolling to arrest on blood vessels: Leukocyte tap dancing on endothelial integrin ligands and chemokines at sub-second contacts. Semin. Immunol. 14 (2002) 93-104
6. Alon R., Grabovsky V., and Feigelson S. Chemokine induction of integrin adhesiveness on rolling and arrested leukocytes local signaling events or global stepwise activation?. Microcirculation 10 (2003) 297-311
7. Ambati J., Anand A., Fernandez S., Sakurai E., Lynn B.C., Kuziel W.A., Rollins B.J., and Ambati B.K. An animal model of age-related macular degeneration in senescent Ccl-2- or Ccr-2-deficient mice. Nat. Med. 9 (2003) 1390-1397
8. Anisowicz A., Bardwell L., and Sager R. Constitutive overexpression of a growth-regulated gene in transformed Chinese hamster and human cells. Proc. Natl. Acad. Sci. USA 84 (1987) 7188-7192
9. Arevalo J.C., and Chao M.V. Axonal growth: Where neurotrophins meet Wnts. Curr. Opin. Cell Biol. 17 (2005) 112-115
10. Bacon K., Baggiolini M., Broxmeyer H., Horuk R., Lindley I., Mantovani A., Maysushima K., Murphy P., Nomiyama H., Oppenheim J., et al. Chemokine/chemokine receptor nomenclature. J. Interferon Cytokine Res. 22 (2002) 1067-1068
11. Bechmann I., Galea I., and Perry V.H. What is the blood-brain barrier (not)?. Trends Immunol. 28 (2007) 5-11
12. Bell M.D., and Perry V.H. Adhesion molecule expression on murine cerebral endothelium following the injection of a proinflammagen or during acute neuronal degeneration. J. Neurocytol. 24 (1995) 695-710
13. Bezzi P., Domercq M., Brambilla L., Galli R., Schols D., de Clercq E., Vescovi A., Bagetta G., Kollias G., Meldolesi J., and Volterra A. CXCR4-activated astrocyte glutamate release via TNFalpha: Amplification by microglia triggers neurotoxicity. Nat. Neurosci. 4 (2001) 702-710
14. Bhattacharyya B.J., Banisadr G., Jung H., Ren D., Cronshaw D.G., Zou Y., and Miller R.J. The chemokine stromal cell-derived factor-1 regulates GABAergic inputs to neural progenitors in the postnatal dentate gyrus. J. Neurosci. 28 (2008) 6720-6730
15. Bonecchi R., Galliera E., Borroni E.M., Corsi M.M., Locati M., and Mantovani A. Chemokines and chemokine receptors: An overview. Front. Biosci. 14 (2009) 540-551
16. Borroni E.M., Bonecchi R., Buracchi C., Savino B., Mantovani A., and Locati M. Chemokine decoy receptors: New players in reproductive immunology. Immunol. Invest. 37 (2008) 483-497
17. Borroni E.M., Buracchi C., Savino B., Pasqualini F., Russo R.C., Nebuloni M., Bonecchi R., Mantovani A., and Locati M. Role of the chemokine scavenger receptor D6 in balancing inflammation and immune activation. Methods Enzymol. 460 (2009) 231-243
18. Brosnan C.F., Bornstein M.B., and Bloom B.R. The effects of macrophage depletion on the clinical and pathologic expression of experimental allergic encephalomyelitis. J. Immunol. 126 (1981) 614-620
19. Burns J.B., Summers B.C., Wang Y., Melikian A., Berahovich R., Miao Z., Penfold M.E.T., Sunshine M.J., Littman D.R., Kuo C.J., et al. A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development. J. Exp. Med. 203 (2006) 2201-2213
20. Butcher E.C. Leukocyte-endothelial cell recognition: Three (or more) steps to specificity and diversity. Cell 67 (1991) 1033-1036
21. Cacalano G., Lee J., Kikly K., Ryan A.M., Pitts-Meek S., Hultgren B., Wood W.I., and Moore M.W. Neutrophil and B cell expansion in mice that lack the murine IL-8 receptor homolog. Science 265 (1994) 682-684
22. Cali C., Marchaland J., Regazzi R., and Bezzi P. SDF 1-alpha (CXCL12) triggers glutamate exocytosis from astrocytes on a millisecond time scale: Imaging analysis at the single-vesicle level with TIRF microscopy. J. Neuroimmunol. 198 (2008) 82-91
23. Cardona A.E., Pioro E.P., Sasse M.E., Kostenko V., Cardona S.M., Dijkstra I.M., Huang D., Kidd G., Dombrowski S., Dutta R., et al. Control of microglial neurotoxicity by the fractalkine receptor. Nat. Neurosci. 9 (2006) 917-924
24. Cardona A.E., Sasse M.E., Mizutani M., Cardona S.M., Liu L., Savarin C., Hu T., and Ransohoff R.M. Scavenging roles of chemokine receptors: Chemokine receptor deficiency is associated with increased levels of ligand in circulation and tissues. Blood 112 (2008) 256-263
25. Carlson T., Kroenke M., Rao P., Lane T.E., and Segal B. The Th17-ELR+ CXC chemokine pathway is essential for the development of central nervous system autoimmune disease. J. Exp. Med. 205 (2008) 811-823
26. Chao M.V., Rajagopal R., and Lee F.S. Neurotrophin signalling in health and disease. Clin. Sci. (Lond.) 110 (2006) 167-173
27. Charo I.F. Fractalkine and atherosclerosis: A new role for a curious chemokine. Blood 97 (2001) 1905
28. Charo I.F., and Peters W. Chemokine receptor 2 (CCR2) in atherosclerosis, infectious diseases, and regulation of T-cell polarization. Microcirculation 10 (2003) 259-264
29. Charo I.F., and Ransohoff R.M. The many roles of chemokines and chemokine receptors in inflammation. N. Engl. J. Med. 354 (2006) 610-621
30. Chen X.K., Xiong Y.F., and Zhou Z. "Kiss-and-run" exocytosis in astrocytes. Neuroscientist 12 (2006) 375-378
31. Cinamon G., Grabovsky V., Winter E., Franitza S., Feigelson S., Shamri R., Dwir O., and Alon R. Novel chemokine functions in lymphocyte migration through vascular endothelium under shear flow. J. Leukoc. Biol. 69 (2001) 860-866
32. Cinamon G., Shinder V., and Alon R. Shear forces promote lymphocyte migration across vascular endothelium bearing apical chemokines. Nat. Immunol. 2 (2001) 515-522
33. Cinamon G., Shinder V., Shamri R., and Alon R. Chemoattractant signals and beta 2 integrin occupancy at apical endothelial contacts combine with shear stress signals to promote transendothelial neutrophil migration. J. Immunol. 173 (2004) 7282-7291
34. Cochran B.H., Reffel A.C., and Stiles C.D. Molecular cloning of gene sequences regulated by platelet-derived growth factor. Cell 33 (1983) 939-947
35. Colobran R., Pujol-Borrell R., Armengol M.P., and Juan M. The chemokine network. I. How the genomic organization of chemokines contains clues for deciphering their functional complexity. Clin. Exp. Immunol. 148 (2007) 208-217
36. Colvin R.A., Campanella G.S., Sun J., and Luster A.D. Intracellular domains of CXCR3 that mediate CXCL9, CXCL10, and CXCL11 function. J. Biol. Chem. 279 (2004) 30219-30227
37. Combadiere C., Feumi C., Raoul W., Keller N., Rodero M., Pezard A., Lavalette S., Houssier M., Jonet L., Picard E., et al. CX3CR1-dependent subretinal microglia cell accumulation is associated with cardinal features of age-related macular degeneration. J. Clin. Invest. 117 (2007) 2920-2928
38. Dambly-Chaudiere C., Cubedo N., and Ghysen A. Control of cell migration in the development of the posterior lateral line: Antagonistic interactions between the chemokine receptors CXCR4 and CXCR7/RDC1. BMC Dev. Biol. 7 (2007) 23
39. Devalaraja R.M., Nanney L.B., Du J., Qian Q., Yu Y., Devalaraja M.N., and Richmond A. Delayed wound healing in CXCR2 knockout mice. J. Invest. Dermatol. 115 (2000) 234-244
40. DeVries M.E., Kelvin A.A., Xu L., Ran L., Robinson J., and Kelvin D.J. Defining the origins and evolution of the chemokine/chemokine receptor system. J. Immunol. 176 (2006) 401-415
41. Dogan R.N., and Karpus W.J. Chemokines and chemokine receptors in autoimmune encephalomyelitis as a model for central nervous system inflammatory disease regulation. Front. Biosci. 9 (2004) 1500-1505
42. El K.J., Toft M., Hickman S.E., Means T.K., Terada K., Geula C., and Luster A.D. Ccr2 deficiency impairs microglial accumulation and accelerates progression of Alzheimer-like disease. Nat. Med. 13 (2007) 432-438
43. Engelhardt B., and Ransohoff R.M. The ins and outs of T-lymphocyte trafficking to the CNS: Anatomical sites and molecular mechanisms. Trends Immunol. 26 (2005) 485-495
44. Fife B.T., Huffnagle G.B., Kuziel W.A., and Karpus W.J. CC chemokine receptor 2 is critical for induction of experimental autoimmune encephalomyelitis. J. Exp. Med. 192 (2000) 899-906
45. Forster R., Mattis A.E., Kremmer E., Wolf E., Brem G., and Lipp M. A putative chemokine receptor, BLR1, directs B cell migration to defined lymphoid organs and specific anatomic compartments of the spleen. Cell 87 (1996) 1037-1047
46. Galea I., Bechmann I., and Perry V.H. What is immune privilege (not)?. Trends Immunol. 28 (2007) 12-18
47. Gaupp S., Pitt D., Kuziel W.A., Cannella B., and Raine C.S. Experimental autoimmune encephalomyelitis (EAE) in CCR2(-/-) mice: Susceptibility in multiple strains. Am. J. Pathol. 162 (2003) 139-150
48. Geissmann F., Jung S., and Littman D.R. Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity 19 (2003) 71-82
49. Geissmann F., Auffray C., Palframan R., Wirrig C., Ciocca A., Campisi L., Narni-Mancinelli E., and Lauvau G. Blood monocytes: Distinct subsets, how they relate to dendritic cells, and their possible roles in the regulation of T-cell responses. Immunol. Cell Biol. 86 (2008) 398-408
50. Glabinski A.R., Tani M., Strieter R.M., Tuohy V.K., and Ransohoff R.M. Synchronous synthesis of alpha- and beta-chemokines by cells of diverse lineage in the central nervous system of mice with relapses of chronic experimental autoimmune encephalomyelitis. Am. J. Pathol. 150 (1997) 617-630
51. Gorbachev A.V., Kobayashi H., Kudo D., Tannenbaum C.S., Finke J.H., Shu S., Farber J.M., and Fairchild R.L. CXC chemokine ligand 9/monokine induced by IFN-gamma production by tumor cells is critical for T cell-mediated suppression of cutaneous tumors. J. Immunol. 178 (2007) 2278-2286
52. Graham G.J., and McKimmie C.S. Chemokine scavenging by D6: A movable feast?. Trends Immunol. 27 (2006) 381-386
53. Gu L., Tseng S.C., and Rollins B.J. Monocyte chemoattractant protein-1. Chem. Immunol. 72 (1999) 7-29
54. Harrison J.K., Jiang Y., Chen S., Xia Y., Maciejewski D., McNamara R.K., Streit W.J., Salafranca M.N., Adhikari S., Thompson D.A., et al. Role for neuronally derived fractalkine in mediating interactions between neurons and CX3CR1-expressing microglia. Proc. Natl. Acad. Sci. USA 95 (1998) 10896-10901
55. Horuk R., Chitnis C.E., Darbonne W.C., Colby T.J., Rybicki A., Hadley T.J., and Miller L.H. A receptor for the malarial parasite Plasmodium vivax: The erythrocyte chemokine receptor. Science 261 (1993) 1182-1184
56. Huang D.R., Wang J., Kivisakk P., Rollins B.J., and Ransohoff R.M. Absence of monocyte chemoattractant protein 1 in mice leads to decreased local macrophage recruitment and antigen-specific T helper cell type 1 immune response in experimental autoimmune encephalomyelitis. J. Exp. Med. 193 (2001) 713-726
57. Huang D., Shi F.D., Jung S., Pien G.C., Wang J., Salazar-Mather T.P., He T.T., Weaver J.T., Ljunggren H.G., Biron C.A., et al. The neuronal chemokine CX3CL1/fractalkine selectively recruits NK cells that modify experimental autoimmune encephalomyelitis within the central nervous system. FASEB J. 20 (2006) 896-905
58. Huising M.O., Stet R.J., Kruiswijk C.P., Savelkoul H.F., and Lidy Verburg-van Kemenade B.M. Molecular evolution of CXC chemokines: Extant CXC chemokines originate from the CNS. Trends Immunol. 24 (2003) 307-313
59. Imitola J., Raddassi K., Park K.I., Mueller F.J., Nieto M., Teng Y.D., Frenkel D., Li J., Sidman R.L., Walsh C.A., et al. Directed migration of neural stem cells to sites of CNS injury by the stromal cell-derived factor 1alpha/CXC chemokine receptor 4 pathway. Proc. Natl. Acad. Sci. USA 101 (2004) 18117-18122
60. Infante-Duarte C., Weber A., Kratzschmar J., Prozorovski T., Pikol S., Hamann I., Bellmann-Strobl J., Aktas O., Dorr J., Wuerfel J., et al. Frequency of blood CX3CR1-positive natural killer cells correlates with disease activity in multiple sclerosis patients. FASEB J. 19 (2005) 1902-1904
61. Izikson L., Klein R.S., Charo I.F., Weiner H.L., and Luster A.D. Resistance to experimental autoimmune encephalomyelitis in mice lacking the CC chemokine receptor (CCR)2. J. Exp. Med. 192 (2000) 1075-1080
62. Jamieson T., Cook D.N., Nibbs R.J., Rot A., Nixon C., McLean P., Alcami A., Lira S.A., Wiekowski M., and Graham G.J. The chemokine receptor D6 limits the inflammatory response in vivo. Nat. Immunol. 6 (2005) 403-411
63. Jung H., Toth P.T., White F.A., and Miller R.J. Monocyte chemoattractant protein-1 functions as a neuromodulator in dorsal root ganglia neurons. J. Neurochem. 104 (2008) 254-263
64. King I.L., Dickendesher T.L., and Segal B.M. Circulating Ly-6C+ myeloid precursors migrate to the CNS and play a pathogenic role during autoimmune demyelinating disease. Blood 113 (2009) 3190-3197
65. Koch M.A., Tucker-Heard G., Perdue N.R., Killebrew J.R., Urdahl K.B., and Campbell D.J. The transcription factor T-bet controls regulatory T cell homeostasis and function during type 1 inflammation. Nat. Immunol. 10 (2009) 595-602
66. Kolodziej A., Schulz S., Guyon A., Wu D.F., Pfeiffer M., Odemis V., Hollt V., and Stumm R. Tonic activation of CXC chemokine receptor 4 in immature granule cells supports neurogenesis in the adult dentate gyrus. J. Neurosci. 28 (2008) 4488-4500
67. Laudanna C., and Alon R. Right on the spot. Chemokine triggering of integrin-mediated arrest of rolling leukocytes. Thromb. Haemost. 95 (2006) 5-11
68. Lauro C., Di A.S., Cipriani R., Sobrero F., Antonilli L., Brusadin V., Ragozzino D., and Limatola C. Activity of adenosine receptors type 1 is required for CX3CL1-mediated neuroprotection and neuromodulation in hippocampal neurons. J. Immunol. 180 (2008) 7590-7596
69. Lazarini F., Tham T.N., Casanova P., Arenzana-Seisdedos F., and Dubois-Dalcq M. Role of the alpha-chemokine stromal cell-derived factor (SDF-1) in the developing and mature central nervous system. Glia 42 (2003) 139-148
70. Lesnik P., Haskell C.A., and Charo I.F. Decreased atherosclerosis in CX3CR1-/- mice reveals a role for fractalkine in atherogenesis. J. Clin. Invest. 111 (2003) 333-340
71. Li M., and Ransohoff R.M. Multiple roles of chemokine CXCL12 in the central nervous system: A migration from immunology to neurobiology. Prog. Neurobiol. 84 (2008) 116-131
72. Lipp M., and Muller G. Shaping up adaptive immunity: The impact of CCR7 and CXCR5 on lymphocyte trafficking. Verh. Dtsch. Ges. Pathol. 87 (2003) 90-101
73. Liu L., Callahan M.K., Huang D., and Ransohoff R.M. Chemokine receptor CXCR3: An unexpected enigma. Curr. Top. Dev. Biol. 68 (2005) 149-181
74. Liu L., Graham G.J., Damodaran A., Hu T., Lira S.A., Sasse M., Canasto-Chibuque C., Cook D.N., and Ransohoff R.M. Cutting edge: The silent chemokine receptor d6 is required for generating T cell responses that mediate experimental autoimmune encephalomyelitis. J. Immunol. 177 (2006) 17-21
75. Liu L., Huang D., Matsui M., He T.T., Hu T., DeMartino J., Lu B., Gerard C., and Ransohoff R.M. Severe disease, unaltered leukocyte migration, and reduced IFN-{gamma} production in CXCR3-/- mice with experimental autoimmune encephalomyelitis. J. Immunol. 176 (2006) 4399-4409
76. Locati M., Torre Y.M., Galliera E., Bonecchi R., Bodduluri H., Vago G., Vecchi A., and Mantovani A. Silent chemoattractant receptors: D6 as a decoy and scavenger receptor for inflammatory CC chemokines. Cytokine Growth Factor Rev. 16 (2005) 679-686
77. Lord G., Rao R.M., Choe H., Sullivan B.M., Lichtman A.H., Luscinskas F.W., and Glimcher L.H. T-bet is required for optimal pro-inflammatory CD4+ T cell trafficking. Blood 85 (2005) 3412-3415
78. Luan J., Shattuck-Brandt R., Haghnegahdar H., Owen J.D., Strieter R., Burdick M., Nirodi C., Beauchamp D., Johnson K.N., and Richmond A. Mechanism and biological significance of constitutive expression of MGSA/GRO chemokines in malignant melanoma tumor progression. J. Leukoc. Biol. 62 (1997) 588-597
79. Ma Q., Jones D., Borghesani P.R., Segal R.A., Nagasawa T., Kishimoto T., Bronson R.T., and Springer T.A. Impaired B-lymphopoiesis, myelopoiesis, and derailed cerebellar neuron migration in CXCR4 or SDF-1 deficient mice. Proc. Natl. Acad. Sci. USA 95 (1998) 9448-9453
80. Mahad D.J., and Ransohoff R.M. The role of MCP-1 (CCL2) and CCR2 in multiple sclerosis and experimental autoimmune encephalomyelitis (EAE). Semin. Immunol. 15 (2003) 23-32
81. Mahad D., Callahan M.K., Williams K.A., Ubogu E.E., Kivisakk P., Tucky B., Kidd G., Kingsbury G.A., Chang A., Fox R.J., et al. Modulating CCR2 and CCL2 at the blood-brain barrier: Relevance for multiple sclerosis pathogenesis. Brain 129 (2006) 212-223
82. Mangalmurti N.S., Xiong Z., Hulver M., Ranganathan M., Liu X.H., Oriss T., Fitzpatrick M., Rubin M., Triulzi D., Choi A., and Lee J.S. Loss of red cell chemokine scavenging promotes transfusion-related lung inflammation. Blood 113 (2009) 1158-1166
83. Mantovani A. The chemokine system: Redundancy for robust outputs. Immunol. Today 20 (1999) 254-257
84. Mantovani A., and Locati M. Housekeeping by chemokine scavenging. Blood 112 (2008) 215-216
85. Mantovani A., Bonecchi R., and Locati M. Tuning inflammation and immunity by chemoattractant decoy receptors: The sound of silence. Nat. Rev. Immunol. 6 (2006) 907-918
86. Martinez de la Torre Y., Locati M., Buracchi C., Dupor J., Cook D.N., Bonecchi R., Nebuloni M., Rukavina D., Vago L., Vecchi A., et al. Increased inflammation in mice deficient for the chemokine decoy receptor D6. Eur. J. Immunol. 35 (2005) 1342-1346
87. Martinez de la Torre Y., Buracchi C., Borroni E.M., Dupor J., Bonecchi R., Nebuloni M., Pasqualini F., Doni A., Lauri E., Agostinis C., et al. Protection against inflammation- and autoantibody-caused fetal loss by the chemokine decoy receptor D6. Proc. Natl. Acad. Sci. USA 104 (2007) 2319-2324
88. Martins-Green M., and Hanafusa H. The 9E3/CEF4 gene and its product the chicken chemotactic and angiogenic factor (cCAF): Potential roles in wound healing and tumor development. Cytokine Growth Factor Rev. 8 (1997) 221-232
89. McCandless E.E., Wang Q., Woerner B.M., Harper J.M., and Klein R.S. CXCL12 limits inflammation by localizing mononuclear infiltrates to the perivascular space during experimental autoimmune encephalomyelitis. J. Immunol. 177 (2006) 8053-8064
90. McCandless E.E., Piccio L., Woerner B.M., Schmidt R.E., Rubin J.B., Cross A.H., and Klein R.S. Pathological expression of CXCL12 at the blood-brain barrier correlates with severity of multiple sclerosis. Am. J. Pathol. 172 (2008) 799-808
91. McCandless E.E., Zhang B., Diamond M.S., and Klein R.S. CXCR4 antagonism increases T cell trafficking in the central nervous system and improves survival from West Nile virus encephalitis. Proc. Natl. Acad. Sci. USA 105 (2008) 11270-11275
92. McColl S.R., Staykova M.A., Wozniak A., Fordham S., Bruce J., and Willenborg D.O. Treatment with anti-granulocyte antibodies inhibits the effector phase of experimental autoimmune encephalomyelitis. J. Immunol. 161 (1998) 6421-6426
93. McDermott D.H., Halcox J.P., Schenke W.H., Waclawiw M.A., Merrell M.N., Epstein N., Quyyumi A.A., and Murphy P.M. Association between polymorphism in the chemokine receptor CX3CR1 and coronary vascular endothelial dysfunction and atherosclerosis. Circ. Res. 89 (2001) 401-407
94. McDermott D.H., Fong A.M., Yang Q., Sechler J.M., Cupples L.A., Merrell M.N., Wilson P.W., D'Agostino R.B., O'Donnell C.J., Patel D.D., and Murphy P.M. Chemokine receptor mutant CX3CR1-M280 has impaired adhesive function and correlates with protection from cardiovascular disease in humans. J. Clin. Invest. 111 (2003) 1241-1250
95. Menetski J., Mistry S., Lu M., Mudgett J.S., Ransohoff R.M., DeMartino J.A., Macintyre D.E., and Abbadie C. Mice overexpressing chemokine ligand 2 (CCL2) in astrocytes display enhanced nociceptive responses. Neuroscience 149 (2007) 706-714
96. Mihara K., Smit M.J., Krajnc-Franken M., Gossen J., Rooseboom M., and Dokter W. Human CXCR2 (hCXCR2) takes over functionalities of its murine homolog in hCXCR2 knockin mice. Eur. J. Immunol. 35 (2005) 2573-2582
97. Milatovic S., Nanney L.B., Yu Y., White J.R., and Richmond A. Impaired healing of nitrogen mustard wounds in CXCR2 null mice. Wound Repair Regen. 11 (2003) 213-219
98. Mildner A., Schmidt H., Nitsche M., Merkler D., Hanisch U.K., Mack M., Heikenwalder M., Bruck W., Priller J., and Prinz M. Microglia in the adult brain arise from Ly-6ChiCCR2+ monocytes only under defined host conditions. Nat. Neurosci. 10 (2007) 1544-1553
99. Moatti D., Faure S., Fumeron F., Amara M., Seknadji P., McDermott D.H., Debre P., Aumont M.C., Murphy P.M., de Prost D., and Combadiere C. Polymorphism in the fractalkine receptor CX3CR1 as a genetic risk factor for coronary artery disease. Blood 97 (2001) 1925-1928
100. Moll N.M., Cossoy M.B., Fisher E., Staugaitis S.M., Tucky B.H., Rietsch A.M., Chang A., Fox R.J., Trapp B.D., and Ransohoff R.M. Imaging correlates of leukocyte accumulation and CXCR4/CXCL12 in multiple sclerosis. Arch. Neurol. 66 (2009) 44-53
101. Nibbs R.J., Gilchrist D.S., King V., Ferra A., Forrow S., Hunter K.D., and Graham G.J. The atypical chemokine receptor D6 suppresses the development of chemically induced skin tumors. J. Clin. Invest. 117 (2007) 1884-1892
102. Okada T., Ngo V.N., Ekland E.H., Forster R., Lipp M., Littman D.R., and Cyster J.G. Chemokine requirements for B cell entry to lymph nodes and Peyer's patches. J. Exp. Med. 196 (2002) 65-75
103. Omari K.M., John G.R., Sealfon S.C., and Raine C.S. CXC chemokine receptors on human oligodendrocytes: Implications for multiple sclerosis. Brain 128 (2005) 1003-1015
104. Omari K.M., John G., Lango R., and Raine C.S. Role for CXCR2 and CXCL1 on glia in multiple sclerosis. Glia 53 (2006) 24-31
105. Omari K.M., Lutz S.E., Santambrogio L., Lira S.A., and Raine C.S. Neuroprotection and remyelination after autoimmune demyelination in mice that inducibly overexpress CXCL1. Am. J. Pathol. 174 (2009) 164-176
106. Padovani-Claudio D.A., Liu L., Ransohoff R.M., and Miller R.H. Alterations in the oligodendrocyte lineage, myelin, and white matter in adult mice lacking the chemokine receptor CXCR2. Glia 54 (2006) 471-483
107. Proudfoot A.E., de Souza A.L., and Muzio V. The use of chemokine antagonists in EAE models. J. Neuroimmunol. 198 (2008) 27-30
108. Pruenster M., Mudde L., Bombosi P., Dimitrova S., Zsak M., Middleton J., Richmond A., Graham G.J., Segerer S., Nibbs R.J., and Rot A. The Duffy antigen receptor for chemokines transports chemokines and supports their promigratory activity. Nat. Immunol. 10 (2009) 101-108
109. Ransohoff R.M. Snip-snip, kill-kill: Truncated SDF-1 and HIV-associated neurodegeneration. Nat. Neurosci. 6 (2003) 1009-1011
110. Ransohoff R.M. Selective leukocyte chemoattractants emerge from the primeval sup(ernatants). J. Immunol. 175 (2005) 5567-5568
111. Ransohoff R.M. Microgliosis: The questions shape the answers. Nat. Neurosci. 10 (2007) 1507-1509
112. Ransohoff R.M., Man S., and Ubogu E.E. "Doing the locomotion" with the multistep paradigm. Blood 109 (2007) 1342-1343
113. Reutershan J. CXCR2-The receptor to hit?. Drug News Perspect. 19 (2006) 615-623
114. Robinson S., Tani M., Strieter R.M., Ransohoff R.M., and Miller R.H. The chemokine growth-regulated oncogene-alpha promotes spinal cord oligodendrocyte precursor proliferation. J. Neurosci. 18 (1998) 10457-10463
115. Rot A. Contribution of Duffy antigen to chemokine function. Cytokine Growth Factor Rev. 16 (2005) 687-694
116. Rot A., and von Andrian U.H. Chemokines in innate and adaptive host defense: Basic chemokinese grammar for immune cells. Annu. Rev. Immunol. 22 (2004) 891-928
117. Saper C.B., and Sawchenko P.E. Magic peptides, magic antibodies: Guidelines for appropriate controls for immunohistochemistry. J. Comp. Neurol. 465 (2003) 161-163
118. Schall T. Fractalkine-A strange attractor in the chemokine landscape. Immunol. Today 18 (1997) 147
119. Schreiber T., Shinder V., Cain D., Alon R., and Sackstein R. Shear flow-dependent integration of apical and subendothelial chemokines in T cell transmigration: Implications for locomotion and the "multi-step paradigm". Blood 109 (2007) 1381-1386
120. Shi F.D., and Van Kaer L. Reciprocal regulation between natural killer cells and autoreactive T cells. Nat. Rev. Immunol. 6 (2006) 751-760
121. Shulman Z., Shinder V., Klein E., Grabovsky V., Yeger O., Geron E., Montresor A., Bolomini-Vittori M., Feigelson S.W., Kirchhausen T., et al. Lymphocyte crawling and transendothelial migration require chemokine triggering of high-affinity LFA-1 integrin. Immunity 30 (2009) 384-396
122. Sierro F., Biben C., Martinez-Munoz L., Mellado M., Ransohoff R.M., Li M., Woehl B., Leung H., Groom J., Batten M., et al. Disrupted cardiac development but normal hematopoiesis in mice deficient in the second CXCL12/SDF-1 receptor, CXCR7. Proc. Natl. Acad. Sci. USA 104 (2007) 14759-14764
123. Stein J.V., Rot A., Luo Y., Narasimhaswamy M., Nakano H., Gunn M.D., Matsuzawa A., Quackenbush E.J., Dorf M.E., and von Andrian U.H. The CC chemokine thymus-derived chemotactic agent 4 (TCA-4, secondary lymphoid tissue chemokine, 6Ckine, exodus-2) triggers lymphocyte function-associated antigen 1-mediated arrest of rolling T lymphocytes in peripheral lymph node high endothelial venules. J. Exp. Med. 191 (2000) 61-76
124. Stellwagen D., and Malenka R.C. Synaptic scaling mediated by glial TNF-alpha. Nature 440 (2006) 1054-1059
125. Strieter R.M., Belperio J.A., Phillips R.J., and Keane M.P. CXC chemokines in angiogenesis of cancer. Semin. Cancer Biol. 14 (2004) 195-200
126. Sunnemark D., Eltayeb S., Nilsson M., Wallstrom E., Lassmann H., Olsson T., Berg A.L., and Ericsson-Dahlstrand A. CX3CL1 (fractalkine) and CX3CR1 expression in myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis: Kinetics and cellular origin. J. Neuroinflammation 2 (2005) 17
127. Tachibana K., Hirota S., Iizasa H., Yoshida H., Kawabata K., Kataoka Y., Kitamura Y., Matsushima K., Yoshida N., Nishikawa S., et al. The chemokine receptor CXCR4 is essential for vascularization of the gastrointestinal tract. Nature 393 (1998) 591-594
128. Tiveron M.C., and Cremer H. CXCL12/CXCR4 signalling in neuronal cell migration. Curr. Opin. Neurobiol. 18 (2008) 237-244
129. Tran P.B., and Miller R.J. Chemokine receptors: Signposts to brain development and disease. Nat. Rev. Neurosci. 4 (2003) 444-455
130. Trettel F., Di A.S., Limatola C., and Ransohoff R.M. Chemokines and chemokine receptors in the nervous system Rome, 27/28 October, 2007. J. Neuroimmunol. 198 (2008) 1-8
131. Tsai H.H., Frost E., To V., Robinson S., ffrench-Constant C., Geertman R., Ransohoff R.M., and Miller R.H. The chemokine receptor CXCR2 controls positioning of oligodendrocyte precursors in developing spinal cord by arresting their migration. Cell 110 (2002) 373-383
132. Tuo J., Smith B.C., Bojanowski C.M., Meleth A.D., Gery I., Csaky K.G., Chew E.Y., and Chan C.C. The involvement of sequence variation and expression of CX3CR1 in the pathogenesis of age-related macular degeneration. FASEB J. 18 (2004) 1297-1299
133. Ward S.G. Millipede-like lymphocyte crawling: Feeling the way with filopodia. Immunity 30 (2009) 315-317
134. White F.A., and Wilson N.M. Chemokines as pain mediators and modulators. Curr. Opin. Anaesthesiol. 21 (2008) 580-585
135. White F.A., Sun J., Waters S.M., Ma C., Ren D., Ripsch M., Steflik J., Cortright D.N., LaMotte R.H., and Miller R.J. Excitatory monocyte chemoattractant protein-1 signaling is up-regulated in sensory neurons after chronic compression of the dorsal root ganglion. Proc. Natl. Acad. Sci. USA 102 (2005) 14092-14097
136. Zaja-Milatovic S., and Richmond A. CXC chemokines and their receptors: A case for a significant biological role in cutaneous wound healing. Histol. Histopathol. 23 (2008) 1399-1407
137. Zampieri N., and Chao M.V. Mechanisms of neurotrophin receptor signalling. Biochem. Soc. Trans. 34 (2006) 607-611
138. Zhang B., Yamamura T., Kondo T., Fujiwara M., and Tabira T. Regulation of experimental autoimmune encephalomyelitis by natural killer (NK) cells. J. Exp. Med. 186 (1997) 1677-1687
139. Zlotnik A., and Yoshie O. Chemokines: A new classification system and their role in immunity. Immunity 12 (2000) 121-127
140. Zou Y.R., Kottmann A.H., Kuroda M., Taniuchi I., and Littman D.R. Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development. Nature 393 (1998) 595-599